Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rienso (ferumoxytol) MRI imaging of atherosclerotic plaque inflammation
2012-005447-25Phase 2Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2013
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of dapirolizumab pegol in atherosclerosis, cardiac morbidity, sponsored by Amsterdam University Medical Center. Started Feb 2013; status: active.
02
Drugs
dapirolizumab pegol
03
Conditions
atherosclerosiscardiac morbidity
Beyond the preview
Go deeper on 2012-005447-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005447-25.